tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mersana Therapeutics Advances HER2-Targeted Cancer Therapy with XMT-2056 Study
PremiumCompany AnnouncementsMersana Therapeutics Advances HER2-Targeted Cancer Therapy with XMT-2056 Study
28d ago
Mersana Therapeutics Settles Debt with Oxford Finance
Premium
Company Announcements
Mersana Therapeutics Settles Debt with Oxford Finance
1M ago
Mersana Therapeutics Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Mersana Therapeutics Approves Key Proposals at Annual Meeting
2M ago
Promising Efficacy and Strategic Positioning of Mersana Therapeutics’ Emi-Le Drive Buy Rating
PremiumRatingsPromising Efficacy and Strategic Positioning of Mersana Therapeutics’ Emi-Le Drive Buy Rating
3M ago
Mersana Therapeutics price target raised to $10 from $9 at Truist
Premium
The Fly
Mersana Therapeutics price target raised to $10 from $9 at Truist
3M ago
Mersana Therapeutics Reports Promising Clinical Advances
Premium
Company Announcements
Mersana Therapeutics Reports Promising Clinical Advances
3M ago
Mersana Therapeutics (MRSN) Q1 Earnings Cheat Sheet
PremiumPre-EarningsMersana Therapeutics (MRSN) Q1 Earnings Cheat Sheet
3M ago
Strategic Restructuring and Focus on Emi-Le Drive Buy Rating for Mersana Therapeutics
Premium
Ratings
Strategic Restructuring and Focus on Emi-Le Drive Buy Rating for Mersana Therapeutics
3M ago
Mersana Therapeutics Announces Strategic Restructuring Plan
Premium
Company Announcements
Mersana Therapeutics Announces Strategic Restructuring Plan
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100